Point72’s Cohen Bets $250 Million on Crowd-Sourced Quantopian
(Bloomberg) -- Point72's Steve Cohen is committing as much as $250 million of capital to be managed by Quantopian Inc., the 5-year-old online platform where members build computerized trading models and earn a share of profits.
Cohen's bet on the Boston-based firm is the first major commitment of funds for Quantopian to manage using its members' algorithms, the company said Wednesday in a statement. Cohen is also making an undisclosed investment in Quantopian through his family-office's venture-capital arm, Point72 Ventures, a “watershed moment for the entire industry” that will enable Quantopian to increase allocations and pay larger royalties to authors of profitable algorithms, Chief Executive Officer John Fawcett said in the statement.
Quantopian's free online platform gives anyone the ability to create and test investment algorithms. With barriers to entry falling in computerized investing, the firm says it has grown to more than 400,000 algorithms written by over 85,000 members from 180 countries. Quantopian, which has held programming contests trading venture-backed capital for more than a year, says it tests each algorithm and makes allocations based on factors such as return and risk, rewarding those whose strategies perform best.
A portion of Cohen's commitment is contingent on Quantopian meeting performance metrics.
“The scarce resource in quantitative investing is talent,” said Matthew Granade, the leader of Point72 Ventures. “Quantopian has demonstrated an innovative approach to finding that talent.”
--With assistance from Dani Burger To contact the reporter on this story: Taylor Hall in New York at thall88@bloomberg.net. To contact the editors responsible for this story: Christian Baumgaertel at cbaumgaertel@bloomberg.net, Josh Friedman, Mary Romano
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets